Climate protesters from This is Rigged blockade two oil sites in bid to ‘shut down the Scottish oil industry’
Marijuana Stocks, Finance, & InvestingUncategorized July 20, 2023
Climate activists step up activities aimed at disrupting Scotland’s oil industry.
Read more‘Going to see a lot of defaults’: $500-billion corporate debt storm is building over global economy
Marijuana Stocks, Finance, & InvestingUncategorized July 20, 2023
The end of the “cheap money era” is producing a nasty hangover for the global economy, according to a top bankruptcy law firm.
Read moreStock market rally broadens as transportation stocks join the 52-week high club
Marijuana Stocks, Finance, & InvestingUncategorized July 20, 2023
The Dow Jones Transportation Index hit a 52-week high on Thursday, joining other high-flying sectors.
Read moreWhy Netflix (NFLX) Stock Is Down Today
Marijuana Stocks, Finance, & InvestingUncategorized July 20, 2023
High expectations and a miss on topline revenues seem to be most responsible for today’s weakness in Netflix.
Read moreGreen groups demand US end talks on natural gas certification
Marijuana Stocks, Finance, & InvestingUncategorized July 20, 2023
The Biden administration’s plan to create a standard for “certified” natural gas is facing stiff opposition from environmental groups.
Read moreatai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
Marijuana Stocks, Finance, & InvestingUncategorized August 15, 2022
Atai reports its Q2 2022 results, announces a new $175 million loan facility and streamlines its operations.
Read moreMindMed Board of Directors Approves Reverse Share Split
Marijuana Stocks, Finance, & InvestingUncategorized August 6, 2022
Mind Medicine announces a reverse share split of its common shares at a 1-15 ratio. Exchange symbols will remain the same but new CUSIP numbers will be assigned by the appropriate regulators.
Read moreCOMPASS Pathways plc announces second quarter 2022 financial results and business highlights
Marijuana Stocks, Finance, & InvestingUncategorized August 5, 2022
Compass Pathways reports its Q2 2022 results. Preparing for its Phase 3 clinical trial for TRD. Net loss of $21.0 million. Cash (and equivalents) of $207.2 million.
Read moreCOMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
Marijuana Stocks, Finance, & InvestingUncategorized July 28, 2022
Compass Pathways announces the launch of a Phase II clinical trial using psilocybin-based COMP360 as a treatment for anorexia nervosa.
Read moreRed Light Holland to Acquire Two Wellness Shops in the Netherlands: SmartShop Utrecht and SmartShop OSS
Marijuana Stocks, Finance, & InvestingUncategorized July 27, 2022
Red Light Holland acquires two of the Netherlands premier shops for psychedelic truffles and wellness products.
Read more